Journal: Current Pharmaceutical Design
Guest editor(s): Marcos Roberto Tovani Palone

Introduction

Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with several factors, including climate change, evolution of microorganisms and decline in vaccination rates. As if that were not enough, the COVID-19 pandemic itself has also exacerbated the burden of many chronic non-communicable diseases, largely due to the restrictive measures necessarily imposed during the most critical periods of the international public health emergency. In the latter case, a combination of risk factors including physical inactivity, smoking, alcohol use and inadequate nutrition may have played a decisive role. As a result, it is of paramount importance to understand and elucidate the current situation and progress achieved. Although different related research has been carried out, there are still important gaps within this perspective that should add relevant knowledge to better direct health management practices, treatment and related innovation. This special issue will focus on the publication of review articles, mini-reviews and original research on pathophysiology, treatments, drugs and vaccines pertinent to the field of emerging and re-emerging diseases including but not limited to:

Keywords

Communicable Diseases, Noncommunicable Diseases , Emerging, Physiopathology, Drug Therapy, Vaccines